查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945110

油溶性金奈米棒市场按材料类型、表面功能化、应用和终端用户产业划分－全球预测，2026-2032年

Oil-soluble Gold Nanorods Market by Material Type, Surface Functionalization, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，油溶性金奈米棒市场价值将达到 4,593 万美元，到 2026 年将成长至 5,288 万美元，到 2032 年将达到 7,237 万美元，复合年增长率为 6.71%。

关键市场统计数据
基准年 2025 4593万美元
预计年份：2026年 5288万美元
预测年份 2032 7237万美元
复合年增长率 (%) 6.71%

对油溶性金奈米棒的科学基础和商业化挑战进行策略性介绍：确定转化研究和开发的优先事项

油溶性金奈米棒代表了奈米工程与应用导向型转化科学的交叉领域，其独特的光学、热学和表面化学性质日益受到研究人员和产品开发人员的青睐。它们异向性的形状和可调谐的等离子体共振使其能够在成像和光热治疗相关的波长范围内与光和热进行精确相互作用，而其油溶性则为在疏水性基质和脂质递送系统中进行製剂开发开闢了新的可能性。

合成技术、表面化学、监管法规的进步以及数位化可追溯性的提升，正在改变油溶性金奈米棒的开发和应用路径。

多种技术和监管变革的融合正在重塑油溶性金奈米棒领域的格局，这些变革加速了转化应用进程，同时也提高了可重复性和安全性方面的要求。合成控制技术的进步使得更精细的长宽比分布和窄频的光学特性成为可能，从而可靠地整合到诊断仪器和光学成像工作流程中。同时，表面涂层技术和功能化化学的创新正在促进金奈米棒在非极性介质中的稳定分散以及对生物分子的选择性结合。

评估美国关税政策对油溶性金奈米棒开发公司采购选择、製造地决策和合作研究趋势的影响

美国和全球贸易政策趋势影响先进材料（包括油溶性金奈米棒）的采购、製造地和伙伴关係策略决策。关税提高了关键原料和成品的到岸成本，促使製造商和创新者重新思考其价值链活动的开展地点和方式。实际上，这种动态正在推动供应商多元化，将采购转向盟国，并在条件允许的情况下增加国内契约製造的使用。

多维細項分析揭示了应用、最终用途、材料类型和表面功能化如何决定开发和商业化优先事项。

全面的市场区隔分析揭示了技术和商业性优先事项的交会点，以及不同应用情境和材料特性所导致的开发路径差异。按应用场景划分，本报告考察了诊断、药物传输、成像和光热治疗市场，并在诊断领域进一步分析了生物感测和癌症诊断。这种细分突显了不同的检验要求：生物感测应用优先考虑表面化学稳定性和优化的信噪比，而癌症诊断则要求严格的特异性和临床检验途径。

战略区域分析：管理体制、製造能力和转化生态系统对美洲、欧洲、中东和非洲以及亚太地区应用的影响

区域特征影响人才、资本、法规结构和製造基础设施的获取，了解这些差异对于制定可行的打入市场策略至关重要。美洲地区集中了众多转化研究中心、临床试验基础设施和合约开发组织，这些机构推动临床研发管线的发展。这种环境使得从实验室发现到临床检验的迭代过程得以快速推进，但也对研发人员提出了严格的监管和品质要求。

竞争格局评估重点阐述了合成规模化生产能力、专有涂层技术和策略伙伴关係关係如何在特殊材料领域创造商业性优势。

油溶性金奈米棒的竞争格局由专业材料开发商、成熟的奈米材料供应商以及连接研发和生产的合约组织共同构成。该领域的领导企业凭藉其在合成规模化方面的深厚专业知识、增强在非极性基质中分散性的专有涂层化学技术以及可实现靶向诊断和治疗应用的检验表面功能化工艺脱颖而出。伙伴关係与授权协议十分普遍，这使得学术研究人员能够获得商业级生产能力和监管方面的专业知识，同时也使企业能够在无需承担全部研发风险的情况下拓展其应用组合。

为经营团队提供切实可行的、优先考虑的建议，以稳定供应链、提高分析严谨性并加速油溶性金奈米棒技术的实用化。

产业领导者应优先采取切实可行的措施，在短期风险缓解与释放长期商业性价值的投资之间取得平衡。首先，应加强关键前驱物和涂层材料的供应商多元化，以降低关税造成的成本波动和供应中断风险。此外，还应建立正式的备选供应商资格认证通讯协定，并维护经过审核的供应商优先名单，以最大限度地减少研发专案的延误。

结合专家访谈、技术检验和三角验证证据的透明混合调查方法，为油溶性金奈米棒的研究提供了可操作的见解。

这些研究结果所依据的研究方法结合了系统性的文献综述、有针对性的专家访谈，以及对公开文件和公司揭露资讯中技术和监管讯号的交叉检验。关键的定性研究内容包括对材料科学家、配方化学家、法规顾问以及在等离子体奈米材料或转化开发流程方面具有直接经验的合约开发组织（CDO）代表的访谈。

本文简要概述了技术、监管和策略的考量因素，这些因素共同构成了油溶性金奈米棒创新技术商业化的切实可行的路径。

油溶性金奈米棒兼具先进材料特性和多样化应用前景，占据着极具吸引力的市场地位。然而，要充分发挥其潜力，必须严格关注可重复性、法规遵循、策略性供应链设计。儘管合成精度、涂层化学和功能化方面的技术进步拓展了其应用范围，但不断变化的监管要求和贸易政策既构成了限制因素，也奖励着研发人员思考如何建立伙伴关係和製造地。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依材料类型分類的油溶性金奈米棒市场

  • 涂层
    • 聚乙二醇涂层
    • 聚合物涂层
    • 二氧化硅涂层
  • 未涂层

9. 依表面功能化分類的油溶性金奈米棒市场

  • 功能化
    • 抗体功能化
    • DNA功能化
  • 不具备功能

第十章 依应用分類的油溶性金奈米棒市场

  • 诊断
    • 生物感
    • 癌症诊断
  • 药物输送
  • 影像
  • 光热治疗

第十一章 依终端应用产业分類的油溶性金奈米棒市场

  • 化妆品
  • 卫生保健
  • 研究所

第十二章 油溶性金奈米棒市场（依地区分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 油溶性金奈米棒市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国油溶性金奈米棒市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 美国油溶性金奈米棒市场

第十六章 中国油溶性金奈米棒市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • American Elements
  • BBI Solutions by Novo Holdings A/S
  • CD Bioparticles
  • Cytodiagnostics Inc.
  • Emfutur Technologies
  • Innova Biosciences
  • Meliorum Technologies, Inc.
  • nanoComposix by Fortis Life Sciences
  • Nanocs, Inc.
  • Nanopartz Inc.
  • Nanoprobes, Inc.
  • Plasmachem GmbH
  • RuixiBiotechCo.Ltd
  • Sigma-Aldrich Corporation
  • TANAKA Holdings Co., Ltd.
Product Code: MRR-8D2A80511E89

The Oil-soluble Gold Nanorods Market was valued at USD 45.93 million in 2025 and is projected to grow to USD 52.88 million in 2026, with a CAGR of 6.71%, reaching USD 72.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 45.93 million
Estimated Year [2026] USD 52.88 million
Forecast Year [2032] USD 72.37 million
CAGR (%) 6.71%

A strategic introduction to the scientific fundamentals and commercialization challenges of oil-soluble gold nanorods that frame translational and development priorities

Oil-soluble gold nanorods represent a convergence of nanoscale engineering and application-driven translational science, offering unique optical, thermal, and surface chemistry attributes that are increasingly attractive to researchers and product developers. Their anisotropic shape and tunable plasmonic resonance enable precise interaction with light and heat at wavelengths relevant to imaging and photothermal modalities, while oil solubility expands formulation possibilities for hydrophobic matrices and lipid-based delivery systems.

Transitioning these materials from research laboratories into regulated applications requires coordinated advances across synthesis reproducibility, surface chemistry control, and scalable coating technologies. Manufacturing reproducibility is critical because subtle variations in aspect ratio, surface ligands, or coating integrity can materially alter biological interaction profiles. At the same time, formulation scientists are exploring how oil-compatible carriers can preserve optical performance while improving biodistribution and interface with existing drug delivery platforms.

Stakeholders should therefore view oil-soluble gold nanorods as both a platform technology and a materials challenge. The platform dimension offers multiple pathways for differentiation in diagnostics, imaging, and targeted therapy contexts, whereas the materials challenge demands systematic attention to interfacial chemistry, solvent compatibility, and analytical methods that verify batch-to-batch consistency. This balanced perspective frames the subsequent analysis of technological shifts, regulatory influences, segmentation dynamics, and regional strategic considerations.

How advances in synthesis, surface chemistry, regulatory rigor, and digital traceability are transforming development and adoption pathways for oil-soluble gold nanorods

The landscape for oil-soluble gold nanorods is being reshaped by several convergent technological and regulatory shifts that are accelerating translational pathways while also raising the bar for reproducibility and safety. Advances in synthetic control now permit tighter aspect ratio distributions and narrower optical signatures, enabling more reliable integration into diagnostic instruments and optical imaging workflows. Alongside these advances, innovations in surface coatings and functionalization chemistries are allowing more stable dispersion in nonpolar media and more selective biomolecular conjugation.

Regulatory expectations are evolving in parallel: agencies are increasingly focused on detailed characterization of nanomaterials, including impurity profiles, coating stability, and the behavior of functionalized surfaces in biological environments. This is prompting developers to improve analytical rigor and to adopt standardized assays that can withstand regulatory scrutiny. In the commercial domain, cross-sector collaboration is becoming a key enabler; diagnostic companies, contract manufacturers, and academic translational centers are forming partnerships to bridge gaps between proof-of-concept studies and clinical-grade production.

At the same time, digital tools for characterization and supply chain traceability are growing in importance. High-resolution imaging, single-particle analytics, and blockchain-enabled provenance tracking are emerging as complementary technologies that increase confidence in quality and origin, which is particularly important for sectors with stringent safety profiles. These transformative shifts are creating a dual imperative: accelerate innovation while investing in robust controls that enable regulatory acceptance and market adoption.

Assessing how US tariff policies influence sourcing, manufacturing location decisions, and collaborative research dynamics for oil-soluble gold nanorod developers

Trade policy developments in the United States and globally influence decisions across sourcing, manufacturing footprint, and partnership strategies for advanced materials such as oil-soluble gold nanorods. Tariff measures can raise the landed cost of key inputs and finished components, prompting manufacturers and innovators to reassess where and how value chain activities are performed. In practice, this dynamic encourages a diversification of suppliers, a shift in procurement toward allied jurisdictions, and increased utilization of domestic contract manufacturing where feasible.

Beyond direct cost implications, tariffs affect the broader ecosystem by altering collaboration incentives. Academic-industry partnerships and cross-border research consortia may face new administrative overhead when material transfers become subject to additional duties or certifications, which can slow iterative experimental cycles. Regulatory harmonization efforts and free trade agreements can mitigate some friction, but uncertainty around policy persistence increases the value of flexible sourcing strategies and dual-sourcing arrangements.

For developers, an effective response to tariff-driven disruption is to combine near-term operational adjustments with medium-term strategic realignment. Near-term tactics include optimizing bill-of-materials visibility, qualifying alternative suppliers for precursors and coatings, and revisiting contractual terms to allocate tariff risk. Over the medium term, investing in regional manufacturing capabilities, forming strategic alliances with local contract manufacturers, and leveraging regulatory compliance as a differentiation point can reduce exposure and preserve time-to-market. These actions maintain continuity in R&D and commercialization pipelines even when trade measures create episodic cost volatility.

Multidimensional segmentation analysis clarifying how application, end use, material type, and surface functionalization dictate development and commercialization priorities

A thorough segmentation lens reveals where technical and commercial priorities concentrate and how development pathways diverge across use cases and material attributes. Based on Application, market is studied across Diagnostics, Drug Delivery, Imaging, and Photothermal Therapy, with Diagnostics further examined across Biosensing and Cancer Diagnostics; this segmentation highlights distinct validation requirements, where biosensing applications emphasize surface chemistry stability and signal-to-noise optimization while cancer diagnostics demand rigorous specificity and clinical validation pathways.

Based on End Use Industry, market is studied across Cosmetics, Healthcare, and Research Organizations, and this distinction clarifies commercialization strategies because cosmetic formulations prioritize safe long-term exposure profiles and aesthetic compatibility, healthcare applications require clinical-grade manufacturing and regulatory dossiers, and research organizations often prioritize material versatility and analytical traceability. Based on Material Type, market is studied across Coated and Uncoated, with the Coated category further subdivided into Polyethylene Glycol Coated, Polymer Coated, and Silica Coated, and the Polyethylene Glycol Coated option further detailed into Methoxy Polyethylene Glycol and Thiol Polyethylene Glycol; these material-type differentiations drive decisions about colloidal stability, circulation times in vivo, and functional handle availability for downstream conjugation.

Based on Surface Functionalization, market is studied across Functionalized and Nonfunctionalized, with the Functionalized subset further defined by Antibody Functionalization and DNA Functionalization; this axis is particularly important because the choice of functionalization method dictates target specificity, batch release criteria, and the complexity of immunogenicity assessment. Taken together, these segmentation frameworks provide a multilayered map that helps developers align technical investments to the regulatory and commercial exigencies of each pathway.

Strategic regional analysis showing how regulatory regimes, manufacturing capabilities, and translational ecosystems influence adoption in the Americas, EMEA, and Asia-Pacific

Regional dynamics shape access to talent, capital, regulatory frameworks, and manufacturing infrastructure, and appreciating these differences is essential for realistic go-to-market strategies. In the Americas, there is a strong concentration of translational research centers, clinical trial infrastructure, and contract development organizations that facilitate clinical pipelines; this environment supports rapid iteration between bench discoveries and clinical validation, although it also imposes stringent regulatory and quality expectations that developers must meet.

In Europe, Middle East & Africa, regulatory landscapes vary significantly, with certain jurisdictions offering harmonized pathways that favor cross-border clinical validation, while others require careful localization of dossiers and manufacturing controls. This region also presents a mature cosmetics market and advanced imaging research communities that can be attractive early adopters for non-therapeutic applications. In Asia-Pacific, rapid manufacturing scale-up capability, a growing base of specialized contract manufacturers, and strong government-supported innovation initiatives create favorable conditions for scaling production and pursuing cost-efficient supply chains; however, developers must navigate diverse regulatory regimes and intellectual property protection frameworks.

These regional differences inform pragmatic choices about where to prioritize pilot production, where to locate analytical laboratories, and how to structure partnerships. A regionally adaptive approach that aligns regulatory strategy, manufacturing capabilities, and commercialization timelines with local strengths reduces execution risk and enhances the probability of successful adoption in each jurisdiction.

Competitive landscape assessment identifying how synthesis scale-up capabilities, proprietary coatings, and strategic partnerships create commercial advantage in this specialized materials sector

The competitive environment for oil-soluble gold nanorods is defined by a mix of specialized materials developers, established nanomaterials suppliers, and contract organizations that bridge R&D to production. Leaders in this space are distinguishing themselves through deep expertise in synthesis scale-up, proprietary coating chemistries that enhance dispersion in nonpolar matrices, and validated surface functionalization processes that enable targeted diagnostic and therapeutic uses. Partnerships and licensing arrangements are common because they allow academic innovators to access commercial-grade manufacturing and regulatory expertise while enabling companies to expand their application portfolios without internalizing all R&D risk.

Investment in analytical platforms and quality systems is another axis of differentiation. Firms that can demonstrate robust characterization of particle size distribution, coating consistency, and functionalization yield are better positioned to support regulated applications. Moreover, strategic collaborations with contract development and manufacturing organizations reduce time-to-clinic for therapeutic applications by combining materials expertise with established GMP processes. In parallel, a subset of companies is focusing on adjacent offerings such as formulation services, assay integration, and platform licensing, creating multiple pathways to monetize core intellectual property.

For potential partners and acquirers, the key indicators of strong capability include a proven route to scale, clear quality control protocols, and an ecosystem of validation partners across preclinical and clinical domains. These strengths lower integration risk and increase the potential for successful downstream commercialization.

Practical, prioritized recommendations for executives to stabilize supply chains, enhance analytical rigor, and accelerate translation of oil-soluble gold nanorod technologies

Industry leaders should prioritize actionable steps that balance near-term risk mitigation with investments that unlock long-term commercial value. First, strengthen supplier diversity for key precursors and coating materials to reduce vulnerability to tariff-driven cost swings and supply disruptions. Establish formal qualification protocols for alternate vendors and maintain a prioritized list of vetted suppliers to minimize delays in development programs.

Second, invest in analytical robustness and documentation. Standardize high-resolution characterization methods and implement traceable quality-control procedures across batches to meet regulatory expectations and to build confidence with clinical and industrial partners. Third, pursue modular manufacturing approaches that allow capacity to be scaled regionally and to be reallocated as policy or demand conditions change; this flexibility is critical for managing trade-related uncertainties and for aligning production with local regulatory requirements.

Fourth, accelerate translational partnerships by co-designing validation studies with end users. Collaborative validation with hospitals, diagnostic labs, or cosmetic formulators shortens feedback loops and clarifies performance requirements. Finally, protect and operationalize intellectual property by aligning patent strategies with commercialization roadmaps and by negotiating licensing terms that support joint development while preserving long-term value. Collectively, these measures create resilient operations and clearer pathways to market.

Transparent mixed-methods research methodology combining expert interviews, technical validation, and triangulated evidence to produce actionable insights on oil-soluble gold nanorods

The research approach supporting these insights combined a systematic literature synthesis, targeted expert interviews, and cross-validation of technical and regulatory signals from public documents and company disclosures. Primary qualitative inputs included interviews with materials scientists, formulation chemists, regulatory consultants, and representatives from contract development organizations, each selected for direct experience with plasmonic nanomaterials or translational development processes.

Analytical methods emphasized triangulation: technical assertions were validated through multiple independent sources, and claims about regulatory trends were corroborated with publicly available guidance documents and precedent submissions where accessible. The methodology also integrated a comparative review of coating and functionalization techniques to identify practical trade-offs between stability in oil-based matrices and the capacity for biomolecular conjugation. Throughout, the emphasis was on reproducible and transparent practices that other researchers and decision-makers can apply when assessing technology readiness and commercial viability.

Limitations are acknowledged: proprietary data from private firms and confidential development programs are by nature not fully visible in the public domain, so conclusions weigh public and expert-validated information more heavily. Nevertheless, this mixed-methods approach yields actionable, evidence-based perspectives that support strategic decision-making for developers, investors, and end users.

A concise synthesis of technical, regulatory, and strategic considerations that defines pragmatic pathways to commercialize oil-soluble gold nanorod innovations

Oil-soluble gold nanorods occupy a compelling niche where advanced material properties intersect with diverse application opportunities, but realizing that potential depends on disciplined attention to reproducibility, regulatory alignment, and strategic supply chain design. Technological advancements in synthesis precision, coating chemistries, and functionalization expand the range of feasible applications, while evolving regulatory expectations and trade policies create both constraints and incentives for how developers structure partnerships and manufacturing footprints.

To move from promise to impact, organizations must integrate rigorous analytical processes, flexible manufacturing strategies, and collaborative validation with end users. Prioritizing supplier diversification, investing in robust characterization platforms, and aligning patent and licensing strategies with commercialization roadmaps are practical steps that reduce execution risk. Regional dynamics should inform where to build capacity and how to sequence market entry, with a focus on harmonizing evidence packages to meet the most demanding regulatory standards likely to be encountered.

In sum, the pathway to commercial success for oil-soluble gold nanorods is navigable for organizations that combine technical excellence with strategic operational planning. Those that do will be well positioned to translate materials innovation into differentiated diagnostic, imaging, and therapeutic solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oil-soluble Gold Nanorods Market, by Material Type

  • 8.1. Coated
    • 8.1.1. Polyethylene Glycol Coated
    • 8.1.2. Polymer Coated
    • 8.1.3. Silica Coated
  • 8.2. Uncoated

9. Oil-soluble Gold Nanorods Market, by Surface Functionalization

  • 9.1. Functionalized
    • 9.1.1. Antibody Functionalization
    • 9.1.2. DNA Functionalization
  • 9.2. Nonfunctionalized

10. Oil-soluble Gold Nanorods Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. Biosensing
    • 10.1.2. Cancer Diagnostics
  • 10.2. Drug Delivery
  • 10.3. Imaging
  • 10.4. Photothermal Therapy

11. Oil-soluble Gold Nanorods Market, by End Use Industry

  • 11.1. Cosmetics
  • 11.2. Healthcare
  • 11.3. Research Organizations

12. Oil-soluble Gold Nanorods Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Oil-soluble Gold Nanorods Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Oil-soluble Gold Nanorods Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Oil-soluble Gold Nanorods Market

16. China Oil-soluble Gold Nanorods Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. American Elements
  • 17.6. BBI Solutions by Novo Holdings A/S
  • 17.7. CD Bioparticles
  • 17.8. Cytodiagnostics Inc.
  • 17.9. Emfutur Technologies
  • 17.10. Innova Biosciences
  • 17.11. Meliorum Technologies, Inc.
  • 17.12. nanoComposix by Fortis Life Sciences
  • 17.13. Nanocs, Inc.
  • 17.14. Nanopartz Inc.
  • 17.15. Nanoprobes, Inc.
  • 17.16. Plasmachem GmbH
  • 17.17. RuixiBiotechCo.Ltd
  • 17.18. Sigma-Aldrich Corporation
  • 17.19. TANAKA Holdings Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYETHYLENE GLYCOL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYETHYLENE GLYCOL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYETHYLENE GLYCOL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SILICA COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SILICA COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SILICA COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY FUNCTIONALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY FUNCTIONALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY FUNCTIONALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DNA FUNCTIONALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DNA FUNCTIONALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DNA FUNCTIONALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY NONFUNCTIONALIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY NONFUNCTIONALIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY NONFUNCTIONALIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOSENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOSENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 140. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 142. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 164. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 166. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 172. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 174. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)